EUVIMEDScopri EUVIMED
Übersichtsarbeit

Indian Experience with Vericiguat: A Review Based upon Case Series

Upendra Kaul, Jamshed Dalal, Jagdish Hiremath, Sandeep Seth, Ashwani Mehta, Nazir Juvale, Pankaj V Jariwala

Journal of The Association of Physicians of India · 2024

DOI: 10.59556/japi.72.0696 ↗

At a glance

Übersichtsarbeit in Journal of The Association of Physicians of India, 2024. Written by Upendra Kaul and 6 co-authors. Institution: Batra Hospital and Medical Research Centre, Delhi, India, Corresponding Author. Major MEDLINE topics: Heart Failure. Cited 1 times so far (Crossref); 28 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Heart failure (HF) is a condition that can result in repeated hospitalizations every year and can result in worsening HF (WHF). Although current pharmacological treatment for HF is fairly effective, there is a need to lower the residual risk of cardiovascular events and hospitalizations. Vericiguat, a soluble guanylate cyclase (sGC) stimulator, a new entrant, seems to present a promising therapeutic option for HF with signs of worsening, and early initiation of this therapy may be beneficial in certain patient profiles. This article explores the potential benefits of early vericiguat initiation in four patient profiles who presented with WHF.

Subjects

MeSH terms (MEDLINE)

Heart FailureAgedFemaleHumansMaleMiddle AgedBenzoatesIndiaPyrimidinesHeterocyclic Compounds, 2-Ring

Substances

BenzoatesPyrimidinesvericiguatHeterocyclic Compounds, 2-Ring

Authors and institutions

  • Batra Hospital and Medical Research Centre, Delhi, India, Corresponding Author.
  • Department of Cardiology, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India.
  • Senior Interventional Cardiologist and Director Cath Lab, Department of Cardiology, Ruby Hall Clinic, Pune, Maharashtra, India.
  • Professor, Department of Cardiology, All India Institute of Medical Sciences, Delhi, India.
  • Department of Cardiology, Sir Ganga Ram Hospital, Delhi, India.
  • Consultant Interventional Cardiologist, Department of Cardiology, Saifee Hospital, Mumbai, Maharashtra, India.

Cite

APA

Kaul, U., Dalal, J., Hiremath, J., Seth, S., Mehta, A., Juvale, N., & Jariwala, P. V. (2024). Indian Experience with Vericiguat: A Review Based upon Case Series. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.72.0696

Vancouver

Kaul U, Dalal J, Hiremath J, Seth S, Mehta A, Juvale N, et al. Indian Experience with Vericiguat: A Review Based upon Case Series. Journal of The Association of Physicians of India. 2024. doi:10.59556/japi.72.0696

BibTeX
@article{Kaul2024,
  author = {Kaul, Upendra and Dalal, Jamshed and Hiremath, Jagdish and Seth, Sandeep and Mehta, Ashwani and Juvale, Nazir and Jariwala, Pankaj V},
  title = {Indian Experience with Vericiguat: A Review Based upon Case Series},
  journal = {Journal of The Association of Physicians of India},
  year = {2024},
  doi = {10.59556/japi.72.0696}
}
Start for free →